2017
DOI: 10.5935/0101-2800.20170037
|View full text |Cite
|
Sign up to set email alerts
|

Reversal of uremic tumoral calcinosis by optimization of clinical treatment of bone and mineral metabolism disorder

Abstract: Tumoral calcinosis is an uncommon type of extraosseous calcification characterized by large rubbery or cystic masses containing calcium-phosphate deposits. The condition prevails in the periarticular tissue with preservation of osteoarticular structures. Elevated calcium-phosphorus products and severe secondary hyperparathyroidism are present in most patients with uremic tumoral calcionosis (UTC). Case report of an obese secondary to chronic glomerulonephritis, undergoing continuous ambulatory peritoneal dialy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…There is no definite treatment of tumoral calcinosis (TC). Medical therapy alone and parathyroidectomy appear to be disappointing, with the complications of postoperative hungry bone disease occurring in the latter (1,2). Cinacalcet is a calcimimetic drug indicated for the treatment of secondary hyperparathyroidism in patients with end-stage kidney disease (ESKD).…”
Section: Editormentioning
confidence: 99%
“…There is no definite treatment of tumoral calcinosis (TC). Medical therapy alone and parathyroidectomy appear to be disappointing, with the complications of postoperative hungry bone disease occurring in the latter (1,2). Cinacalcet is a calcimimetic drug indicated for the treatment of secondary hyperparathyroidism in patients with end-stage kidney disease (ESKD).…”
Section: Editormentioning
confidence: 99%
“…Current treatments consist of dietary phosphorus restriction, oral administration of intestinal phosphate binders, oral or intravenous calcitriol, oral calcimimetic agents (cinacalcet), and intensive hemodialysis with low calcium dialysate. Surgical excision of tumoral calcinosis, parathyroidectomy, and kidney transplantation are recommended for persistent or refractory cases [1,2]. Here we report a patient with ESRD complicated by metastatic calcification.…”
Section: Introductionmentioning
confidence: 96%
“…Elevated levels of calcium-phosphorus products and severe secondary hyperparathyroidism are present in these patients. Common sites of involvement include blood vessels, the periarticular region, heart, lungs, kidneys, gastric mucosa, central nervous system, breasts, and eyes [1]. Secondary hyperparathyroidism is an important complication of chronic kidney disease (CKD) and end stage renal disease (ESRD).…”
Section: Introductionmentioning
confidence: 99%